Credits: Canva
As per the latest data released by Transforming Access to Student Outcomes in Higher Education (TASO) and the Policy Institute at King's College London, the number of UK students reporting mental health difficulties tripled. The estimate reveals that around 300,000 students could now be experiencing mental health struggles. Of the total, 18% of students reported some kind of mental health issue in 2024.
As per the reports, this estimate is triple what was reported in 2017, where it was at 6%. Experts also say that Covid-19 pandemic is "often considered to have contributed to this, it does not explain the ongoing rise in mental health difficulties." Another reason could also be the "changing definition and increasing openness about mental health" which has led to a rise in numbers. The report notes, "This trend pre-dates the Covid-19 pandemic and the cost-of-living crisis. Although these factors play a part in students' deteriorating mental health, they cannot therefore be the only explanation."
The report drew data collected over the latest Student Academic Experience Survey of 93,212 students. From the survey, it was found that there exist significant disparities between demographic groups, with women being twice as likely to report mental health difficulties, about 22% as compared to men, at 11%.
The results revealed that students who identified as LGBTQ experienced the highest rates of mental health challenges. This has actually lessened the hope that conditions for LGBTQ students are improving, which may not have been a positive case.
Of them, 42% are bisexual and lesbian students, whereas last year it was 35% and 32% respectively. The report also noted that mental health difficulties among lesbian women and gay men rose three times the rate of straight people, and among bisexual and asexual people, it was twice as high. For trans students, the number jumped from 25% in 2023 to 40% in 2024.
As per the Child Mind Institute, being LGBTQ+ does not cause mental health problems, but because these kids often face factors like rejection, discrimination and violence, they are at a higher risk of challenges including depression, anxiety, and even attempting suicide.
A UTAH Health study quotes Anna Docherty, PhD, LP, assistant professor of psychiatry at Huntsman Mental Health Institute that, "likely with any identity, feeling different - or worse, unaccepted as you are is a significant risk factor of mental health struggle." The data reveals that LGBTQ+ teens are six times more likely to experience symptoms of depression than non-LGBTQ+ identifying teens. They are also more than twice as likely to feel suicidal and more than four times as likely to attempt suicide. In the US alone, 48% of transgender adults report that they have considered suicide in the last year, compared to 4% of the overall population.
TASO's academic lead and professor of public policy at King's College London, Michael Sanders said, "LGBTQ students and women bear the brunt of the rise in declining mental health and urgent action is needed to understand and address these trends."
The Ebola outbreak in the Democratic Republic of the Congo (DRC), driven by the Bundibugyo virus, continues to grow rapidly.
According to the latest government data, the number of confirmed cases in the DRC has risen to 1,118, including 291 deaths.
As of June 24, Uganda had reported 20 confirmed cases, including two deaths. The most recent case was reported on June 21, and no new cases have been recorded since.
Among the confirmed cases in Uganda, 15 had travel links to the DRC and five were linked to local transmission.
Outside Africa, France has reported a confirmed Ebola case in a doctor who returned from a humanitarian mission in Ituri province, the hardest-hit region in the DRC, with 997 confirmed cases and nearly 280 deaths.
Also read: Ebola Bundibugyo Strain: All You Should Know About The Rare Virus
Bundibugyo is one of the rarest Ebola virus strains. There have been only two previous outbreaks: one in Uganda in 2007 and another in the DRC in 2012, with case fatality rates of 32% and 55%, respectively.
A key difference is that there is currently no approved vaccine for the Bundibugyo strain. Vaccines are available for the Sudan and Zaire Ebola strains, but treatment for the Bundibugyo virus remains limited to supportive care.
In a Correspondence published in The New England Journal of Medicine (NEJM), researchers from the Institut National de Santé Publique in Kinshasa analyzed the clinical characteristics of Bundibugyo virus disease (BVD).
Researchers recorded symptoms in 405 patients with confirmed BVD and 516 people who tested negative.
Among confirmed BVD patients, the most common symptoms were:
Notably, bleeding-related symptoms, often associated with Ebola, were relatively uncommon and were reported in only 10.4% of patients at presentation.

Read More: Global Hantavirus Response To End On July 2: WHO
The symptom profile was largely similar across age groups and between men and women. However, fever was slightly less common among men, while headaches became less frequent with increasing age. Men were also somewhat more likely to report cough and chest pain, the researchers said.
Compared with people who tested negative, patients with confirmed BVD were much more likely to experience gastrointestinal and systemic symptoms.
The researchers reviewed 2,351 recorded cases in the individual-level database for BVD between May 3 and June 8, 2026.
Of these, 505 patients (21.5%) had laboratory-confirmed BVD based on PCR testing, while 635 patients (27.0%) who were suspected of having the disease tested negative.
Researchers noted that patients with confirmed BVD were demographically similar to those who tested negative. In both groups, most patients were adults aged 20 to 39 years, and women slightly outnumbered men.
Among 253 patients with laboratory-confirmed infection tested using the RADIONE PCR assay in Bunia, Ituri Province, researchers found that patients who died generally had lower cycle-threshold (Ct) values, indicating a higher viral load, than those who survived.
Among 129 patients with available symptom-onset and sample-collection dates, the mean delay between symptom onset and testing was 7.4 days, with a median delay of 4.8 days.
Earlier diagnosis and treatment could improve survival rates and help reduce virus transmission within communities, the researchers said.
Credit: iStock
Europe is facing a record heatwave, and the extreme heat has reportedly claimed 212 lives in Spain between June 21 and June 24, according to estimates from a public institute.
The estimate is based on the MoMo monitoring system, which collects daily statistics on deaths in Spain and calculates variations in mortality by comparing them with predictable levels based on historical data.
Mainland Spain this week recorded its highest daily average temperatures in June since at least 1950, with Monday's figure of 28.08°C followed by 28.17°C on June 23, AFP reported.
Those two days also marked the highest average minimum temperatures for June since 1950, with 20.14°C recorded on Monday and 19.81°C on June 23. These so-called "tropical nights" make sleep challenging and can threaten public health.
Spain had also recorded its highest heat-related mortality for the month of May since records began in 2015, as per data from the Health Ministry. As per the MoMo system, May 2026 recorded 101 deaths attributable to high temperatures, the highest figure for this month since the series began in 2015.
Also read: WHO Sounds Alarm on Europe's Extreme Heat: Here's How Hot It Could Get Across Countries
The extreme heat is not limited to Spain. The June 2026 heatwave has triggered red alerts across France, Spain, Italy, and the United Kingdom, and killed dozens of people.
In France, the heatwave forced the early closure of major Paris tourist attractions, including the Eiffel Tower and the Louvre Museum. At least 40 people have drowned seeking relief from the heat since June 18, as per the French Prime Minister
Poultry farmers across France say that hundreds of thousands of their livestock have died during the extreme heat.
The UK has provisionally recorded its warmest June night on record, surpassing a record set in 1976. Temperatures could climb to 37-38°C, potentially breaking the June heat record for a second consecutive day.
In Italy, heatwave leaves 4 dead as 17 cities face red alert. Authorities warn even healthy people are at risk as temperatures remain dangerously high.
“Europe’s heatwave is closing schools and putting people’s health at risk. The data are clear: temperatures across Europe are rising at roughly twice the global average rate, increasing the likelihood and severity of extreme heat in the future,” Tedros Adhanom Ghebreyesus, WHO Director-General, shared in a post on social media platform X.
“We cannot afford further delay. Leaders must prioritize investment in climate-resilient health systems, while also accelerating #ClimateAction and mitigating the drivers of the climate crisis,” he added.
Read To Know: UK Met Office Warns of 'Pollen Bomb': What Hay Fever Patients Need to Know
According to meteorologists, the soaring temperatures are being driven by a weather pattern known as an "omega block".
This blocks cooler Atlantic air from entering the region while drawing hot air northward from North Africa and the Sahara. The persistent high-pressure system acts like a lid, trapping heat near the ground and allowing temperatures to climb steadily over several days.
Health experts warn that prolonged exposure to extreme heat can have serious and sometimes fatal consequences, particularly for older adults and people with underlying medical conditions.
According to the WHO, extreme heat can overwhelm the body's ability to regulate temperature, increasing the risk of heat exhaustion and heatstroke. As the body works harder to cool itself, it places added strain on the heart and kidneys, potentially worsening chronic conditions such as cardiovascular, respiratory, mental health and diabetes-related illnesses, and increasing the risk of acute kidney injury.
The health impact of heat depends on factors such as its intensity, duration and timing, as well as how well people and local systems are adapted to high temperatures.
Tips to Beat the Heat:
To reduce the health risks associated with extreme temperatures, the WHO suggested to:
Credit: iStock
India has taken a significant step to strengthen the safety and authenticity of medicines by expanding its QR code-based drug traceability system.
The Ministry of Health and Family Welfare has amended the Drugs Rules, 1945, bringing additional categories of medicines—including vaccines, anti-cancer drugs and antimicrobials—under the Schedule H2 track-and-trace framework.
The move is aimed at enhancing supply chain transparency, curbing counterfeit medicines and enabling patients to verify key details about their medicines through a simple QR code scan.
In 2025, the government made it mandatory for the top 300 pharmaceutical companies to print or affix QR (Quick Response) codes on the packaging of the medicines they sell.
The new amendment significantly expands its coverage to include:
Also read: India Ends OTC Sale of Cough Syrups, Doctor's Prescription Now Mandatory
The amendment applies to all vaccines, antimicrobials, narcotic and psychotropic drugs covered under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985.
All anti-cancer drugs have also been included under Schedule H2 of the Drugs Rules, 1945.
According to the Health Ministry, manufacturers of these drug formulations will now be required to print or affix a Bar Code or Quick Response (QR) Code on the primary packaging label of the product or, where there is inadequate space, on the secondary packaging label.
The QR code shall store information that can be accessed through software applications to facilitate authentication and verification of the product throughout the supply chain.
The QR code will contain key product information, including:
Read More: Sleeping Too Little or Too Much? Neurologist Explains Health Risks
The enhanced traceability mechanism is aimed at facilitating authentication of medicines at various stages of the supply chain and enabling improved tracking and verification of drug products, the Ministry noted.
The measure is expected to strengthen regulatory oversight and support efforts to curb the distribution of spurious medicines in the market.
It will also contribute to the national fight against antimicrobial resistance (AMR) by enabling better identification and monitoring of counterfeit and substandard antimicrobial products.
Recognizing the need to provide adequate time to industry and other stakeholders for implementation, the Ministry has also prescribed phased timelines for compliance.
As per the Ministry, the provisions relating to vaccines, narcotic and psychotropic drugs, and anti-cancer medicines shall come into force from July 1, 2027.
The provisions relating to antimicrobials shall become effective from July 1, 2028.
The government's QR code move comes amid mounting concern over counterfeit and substandard medicines in the Indian market.
In May, the Central Drugs Laboratories identified 46 drug samples as Not of Standard Quality (NSQ), while State Drugs Testing Laboratories identified 113 drug samples as Not of Standard Quality (NSQ), according to the Health Ministry.
Further, one drug sample from Assam was identified as a spurious drug. It was manufactured by unauthorized manufacturers using a brand name owned by another company. The matter is under investigation and action will be taken as per the Act and Rules.
© 2024 Bennett, Coleman & Company Limited